Glaukos Corporation stocks have been trading up by 11.67 percent following strong clinical trial progress and regulatory momentum news. Key Takeaways Positive three-year Epioxa data in keratoconus ...
A simulation of German electricity data suggests dynamically idling research computing clusters can cut carbon emissions by ...
An analysis of 15 million geotagged tweets shows how New York City's online conversation about transit, retail, culture, and ...
Huaneng Power International shares closed at HK$5.835 on 28 October, leaving the stock slightly lower over the past month and ...
In the closing days of the midterms, the Trump administration has sent multiple states lists of what it alleges are ...
Boston Scientific reported mixed third-quarter 2026 results, with adjusted earnings per share of $0.73 coming in below the $0 ...
Why 65% of New AI Code Contains Vulnerabilities Despite '50 Years of Bug Discovery'If someone said in a company meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results